Use of an α3β4 nicotinic acetylcholine receptor subunit concatamer to characterize ganglionic receptor subtypes with specific subunit composition reveals species-specific pharmacologic properties.
about
Enantiopure Cyclopropane-Bearing Pyridyldiazabicyclo[3.3.0]octanes as Selective α4β2-nAChR Ligands.Nicotinic receptors in non-human primates: Analysis of genetic and functional conservation with humans.The minimal pharmacophore for silent agonism of the α7 nicotinic acetylcholine receptor.The novel α7β2-nicotinic acetylcholine receptor subtype is expressed in mouse and human basal forebrain: biochemical and pharmacological characterization.AT-1001 Is a Partial Agonist with High Affinity and Selectivity at Human and Rat α3β4 Nicotinic Cholinergic Receptors.Differential modulation of brain nicotinic acetylcholine receptor function by cytisine, varenicline, and two novel bispidine compounds: emergent properties of a hybrid molecule.The effects of noncontingent and self-administered cytisine on body weight and meal patterns in male Sprague-Dawley rats.Varenicline and cytisine diminish the dysphoric-like state associated with spontaneous nicotine withdrawal in rats.Similar activity of mecamylamine stereoisomers in vitro and in vivoHuman nicotinic receptors in chromaffin cells: characterization and pharmacology.Nicotinic acetylcholine receptors in neuropathic and inflammatory pain.Therapeutic concentrations of varenicline in the presence of nicotine increase action potential firing in human adrenal chromaffin cells.
P2860
Q27335322-655F97BA-8C7F-4622-BE69-5E91287DE4D5Q30371523-6DB046B2-8F28-42D5-B831-A82EDFD57B8EQ34125095-D52AC630-A76F-4E39-9B1E-B977BCC3FA62Q34125225-D45A75F4-50CF-4625-A274-2B74BD939527Q36077726-56E8E860-F2DA-4FC6-81FE-A120B9235724Q37252061-E50EDF8C-42B3-4990-9344-58D9D3E6C472Q37359319-8FAE58E7-0E5B-4C9B-BD1A-001C397969C0Q37409561-F06AAE47-D68C-46F3-846C-8303EB21FDA8Q37712056-1EF463A7-7502-46A8-A1E1-2B0459355839Q46277774-7734945B-CF10-457B-9E5B-994EC13635D7Q47739924-40BFF6C3-9006-44D5-A4AC-B6FEB0CC4989Q48037427-887965FD-3AA0-4320-A81A-96243A3E36E2
P2860
Use of an α3β4 nicotinic acetylcholine receptor subunit concatamer to characterize ganglionic receptor subtypes with specific subunit composition reveals species-specific pharmacologic properties.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Use of an α3β4 nicotinic acety ...... ific pharmacologic properties.
@en
type
label
Use of an α3β4 nicotinic acety ...... ific pharmacologic properties.
@en
prefLabel
Use of an α3β4 nicotinic acety ...... ific pharmacologic properties.
@en
P2860
P1433
P1476
Use of an α3β4 nicotinic acety ...... ific pharmacologic properties.
@en
P2093
Clare Stokes
Roger L Papke
P2860
P304
P356
10.1016/J.NEUROPHARM.2012.04.035
P577
2012-05-11T00:00:00Z